Led · Seed · Mar 2026

EGI Battery designs and manufactures advanced lithium-ion batteries tailored for dual-use aerospace, unmanned systems, robotics, and other mission-critical markets. Headquartered in Ann Arbor, Michigan, the company emphasizes a fully domestic, secure supply chain and targets ISO 9001 and AS9100 quality certifications. Its Zeeb Campus serves as the focal point for scaling production, with a goal of reaching at least 95% NDAA-compliant materials by cost in 2028. The firm is led by seasoned battery industry veterans and is actively building intellectual property and manufacturing capabilities to support a 2026 commercial expansion plan. The newly raised seed capital supports campus expansion, continued product engineering, and deepening of domestic supply-chain partnerships. Although specific revenue or user metrics were not disclosed, the successful seed raise underscores market demand for domestically produced, high-performance batteries. EGI’s roadmap positions it to become a key domestic supplier to aerospace, defense, and critical infrastructure customers.

Participated · Seed · Feb 2026

Expert Intelligence is a Santa Clara startup developing a Limited Sample Model (LSM) platform that learns expert decision processes directly from raw laboratory instrument signals, eliminating the need for large labeled datasets. By focusing on auditability, traceability, and compliance, the system aims to replace slow, manual expert reviews that currently constrain throughput in pharmaceuticals, drug manufacturing, and food and beverage safety labs. The company positions its technology as foundational infrastructure for autonomous decision-making in high-compliance environments where data is scarce and tightly controlled. Commercial deployments are slated to begin in early 2025, and the firm says it has already secured initial customers across multiple analytical testing workflows. Future road-map targets include diagnostics, environmental monitoring, advanced materials, and chemical manufacturing. Founded by AI engineer Lalin Theverapperuma, Ph.D., the company has raised $5.8 million in seed funding to accelerate customer expansion, deepen integrations with lab systems, and build go-to-market and customer success functions.

Participated · Series B · Dec 2025

Angle Health provides an AI-powered, vertically integrated platform that combines underwriting, claims administration, and member engagement to streamline employer-sponsored health benefits. Its benefit-builder and quote-to-card tools let brokers generate firm underwritten quotes in minutes using only a census and activate groups in real time. The platform connects employers and employees to tailored healthcare plans, aiming to make benefits administration faster and more transparent. Led by CEO Ty Wang, the company plans to use new capital to expand operations and accelerate product development. Angle Health positions itself as a solution for businesses of any size seeking custom benefits packages and a consumer-grade healthcare experience. With the latest financing, the company’s total funding approaches $200 million, underscoring strong investor confidence in its growth trajectory.

Participated · Seed · Nov 2025

IndustrialMind.ai is developing an AI-powered engineer service designed for manufacturers that can understand engineering drawings and real-time production data, then recommend and validate process changes. Its platform offers drawing-to-process automation, continuous monitoring, and root-cause analysis aimed at lifting yield, boosting throughput, and improving overall equipment effectiveness. The company currently supports manufacturers across North America and the Asia-Pacific region. Led by CEO Steven Gao and headquartered in San Francisco, the team positions its product as a digital co-engineer that shortens new-product-introduction timelines. With newly secured capital, IndustrialMind.ai plans to accelerate product development and expand customer deployments. To date, the company has raised $1.2 million in external financing, which constitutes its pre-seed round. No other operating metrics, such as revenue or user counts, were disclosed in the article.

Led · Series A · Oct 2025

Petal Surgical is developing an incisionless surgery platform that uses Millisecond Pulse Histotripsy — a form of acoustic liquefaction — integrated with robotics, imaging and AI-driven controls to precisely treat tissue. The platform creates vapor-filled cavities one at a time to enable connected treatment regions and break down tougher tissues without cutting. The company says its approach aims to eliminate cuts, pain, trauma and other typical surgical risks and to leverage the body's natural healing. Petal plans to use recent financing to accelerate R&D, expand clinical readiness activities and advance toward first-in-human studies. The company was founded by image-guided surgery engineer Prash Chopra alongside neurosurgeon Dr. Bowen Jiang, spine-surgery pioneer Dr. Nicholas Theodore, and Rony Abovitz, a founder of Mako Surgical. Petal has drawn board and investor support from figures such as Dr. Fred Moll and Lip-Bu Tan.